Open AccessShort-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study
Author(s) -
Sebastian Schneeweiß,
Peggy L. Carver,
Kausik Datta,
Alicia Galar,
Melissa D. Johnson,
Matthew G. Johnson,
Francisco M. Marty,
Jerod Nagel,
Maryann Najdzinowicz,
Melissa Saul,
Shmuel Shoham,
Fernanda P. Silveira,
Christy Varughese,
Marissa B. Wilck,
Lisa B. Weatherby,
Tim Auton,
Alexander M. Walker
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw225
Subject(s) - micafungin , medicine , renal function , cohort , adverse effect , gastroenterology , antifungal , amphotericin b , dermatology
Although echinocandins are generally well tolerated, there is little information on the frequency with which renal and hepatic adverse effects occur during use of micafungin or other parenteral antifungal (PAF) agents in clinical practice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom